Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 894-897

  Wananukul, S ^a   Chatproedprai, S ^a   Charutragulchai, W ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LICOCHALCONE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; HUMIDIFIER; INFANT; INFANTILE SEBORRHEIC DERMATITIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEBORRHEIC DERMATITIS;

ADMINISTRATION, TOPICAL; CHALCONES; DERMATITIS, SEBORRHEIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862755457     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04187.x     Document Type: Article

References (21)

1. Chatproedprai S, Wananukul S,. Survey of common cutaneous lesion in healthy infants at the well baby clinic. J Med Assoc Thai 2008; 91: 1356-1359.
2. Foley P, Zuo Y, Plunkelt A, Merlin K, Marks R,. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 2003; 139: 318-322. (Pubitemid 36335764)
3. Elish D, Silverberg NB,. Infantile seborrheic dermatitis. Cutis 2006; 77: 297-300. (Pubitemid 43845321)
4. Wananukul S, Chindamporn A, Yumyourn S, Samathi C, Poovorawan Y,. Malassezia furfur in seborrheic dermatitis. Asian Pac J Allergy Immunol 2005; 23: 101-105.
5. Tollesson A, Frithz A, Stenlund K,. Malassezia furfur in infantile seborrheic dermatitis. Pediatr Dermatol 1997; 14: 423-425. (Pubitemid 28012017)
6. Broberg A, Faegermann J,. Infantile seborrheic dermatitis and pityrosporum ovale. J Dermatol 1994; 21: 334-340.
7. Hogan PA, Langley R,. Papulosquamous disease. In, Schachner LA, Hansen RC, eds. Pediatric Dermatology, 4th edn. Mosby Elsevier, China, 2011, P901-P951.
8. Wananukul S, Chiabunkana J,. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thai 2004; 87: S68-S71. (Pubitemid 41032722)
9. Taieb A, Leigrain V, Palmier C, Lejean S, Six M, Maleville S,. Topical ketoconazole for infantile seborrheic dermatitis. Dermatologica 1990; 182: 26-32. (Pubitemid 20207395)
10. Zeharia A, Mimouni M, Fogel D,. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Pediatr Dermatol 1996; 13: 151-153. (Pubitemid 26131966)
11. Brodell R, Patel S, Venglarick J,. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol 1988; 15: 406-407.
12. Kolbe L, Immeyer J, Batzer J, et al. Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 2006; 298: 23-30. (Pubitemid 43725209)
13. The Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of glycerrhetinic acid, potassium glycyrractinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycerrhizate, dipotassium glycyrrhizate, disodium glycyrrhizate, trisodium glycyrrhizate, methyl glycyrrhizate and potassium glycyrrhizinate. Int J Toxicol 2007; 26: S79-S112.
14. Weber TM, Ceilley RI, Buerger A, et al. Skin tolerance, efficacy and quality of life of patients with red facial skin using a skin care regimen containing licochalcone A. J Cosmet Dermatol 2006; 5: 227-232. (Pubitemid 44314384)
15. Saeedi M, Morteza-Semnani K, Ghoreishi MR,. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 2003; 14: 153-157. (Pubitemid 37254627)
16. Udompataikul M, Srisatwaja W,. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol 2011; 25: 660-665.
17. Schwartz RA, Janusz CA, Janniger CK,. Seborrheic dermatitis: an overview. Am Fam Physician 2006; 74: 125-130. (Pubitemid 44049740)
18. Faergemann J,. Seborrheic dermatitis and Pityrosporum orbiculare: treatment of the seborrheic dermatitis of the scalp with miconazole- hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695-700. (Pubitemid 16079770)
19. Barfod L, Kemp K, Hansen M, Kharazmi A,. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int Immunopharmacol 2002; 2: 545-555. (Pubitemid 34169749)
20. 2 production in human skin fibroblasts. J Pharm Pharmacol 2005; 57: 1661-1666. (Pubitemid 41752280)
21. Tsukiyama R, Katsura H, Tokuriki N, Kobayashi M,. Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 2002; 46: 1226-1230. (Pubitemid 34415295)